TJ 114
Alternative Names: Sairei-to; SairetoLatest Information Update: 31 May 2004
At a glance
- Originator Nonindustrial source; Tsumura
- Class Antipsoriatics; Antirheumatics; Phytotherapies
- Mechanism of Action Antioxidants; Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Crohn's disease; Ulcerative colitis
- No development reported Diabetic nephropathies; Genitourinary disorders; Rheumatoid arthritis
Most Recent Events
- 31 May 2003 No development reported - Clinical-Phase-Unknown for Genitourinary disorders in Japan (unspecified route)
- 09 May 2003 No development reported - Clinical-Phase-Unknown for Diabetic nephropathies in Japan (PO)
- 25 Mar 1999 No-Development-Reported for Rheumatoid arthritis in USA (Unknown route)